KOE · 468530.KQ
Proteina Co., Ltd.
₩54,300+₩400 (+0.74%)
Proteina Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 54.79% below the high.
Loading market information…
KOE · 228760.KQ · KRW
Stock price, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
Genomictree Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.06% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Genomictree Inc.’s next earnings report is currently expected on Nov 6, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Genomictree Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to develop and market advanced detection tools for both oncological conditions and various infectious diseases. Its product line includes EarlyTect C, a screening solution for the early identification of colorectal cancer. For lung cancer, it offers EarlyTect L, which targets epigenetic markers in patients with pulmonary nodules, and for bladder cancer, EarlyTect B, designed to detect specific genetic and epigenetic markers in individuals with hematuria. The company also provides a range of companion diagnostics: AccuraTect-KRAS and AccuraTect-BRAF assist in colorectal cancer management, while AccuraTect-EGFR supports lung cancer treatment. In addition, Genomictree supplies AccuraDTect SARS-CoV-2 RT-qPCR kits for infectious disease testing, and offers its technologies to support various diagnostic test providers. Founded in 2000, the company is based in Daejeon, South Korea.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:38 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Jun 29, 2024 |
| -₩118 |
| ₩559.78M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩54,300+₩400 (+0.74%)
Proteina Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 54.79% below the high.
₩12,110-₩510 (-4.04%)
Onconic Therapeutics’s quoted price sits in the lower half of its reported 52-week range, 58.1% below the high.
₩9,140+₩20 (+0.22%)
GC Corp.’s quoted price sits in the lower half of its reported 52-week range, 49.25% below the high.
₩15,320-₩490 (-3.1%)
Orum Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 89.55% below the high.
₩8,090-₩260 (-3.11%)
MEDIPOST Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 72.2% below the high.
₩2,020-₩40 (-1.94%)
SillaJen, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.59% below the high.
₩6,030-₩50 (-0.82%)
BINEX Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 64.11% below the high.
₩6,810-₩170 (-2.44%)
Bioneer Corporation’s quoted price sits in the lower half of its reported 52-week range, 62.06% below the high.
